Catalyst Pharmaceutical Partners Inc buy Robert W. Baird
Start price
03.03.25
/
50%
€22.15
Target price
03.03.26
€30.55
Performance (%)
-11.83%
Price
09.01.26
€19.53
Summary
This prediction is currently active. The price of Catalyst Pharmaceutical Partners Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.83%. This prediction currently runs until 03.03.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | -1.164% | -1.164% |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by Robert_W__Baird for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Robert W. Baird from $28.00 to $32.00. They now have an "outperform" rating on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Robert_W__Baird for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€22.14
04.02.25
04.02.25
€27.08
04.02.26
04.02.26
-11.79%
09.01.26
09.01.26
